Altered proliferative responses of dermal fibroblasts to TGF-β1 may contribute to chronic venous stasis ulcer

Journal of Vascular Surgery

Volumn 37, Issue 6, 2003, Pages 1285-1293

  Lal, Brajesh K ^a,b   Saito, Satoshi ^a   Pappas, Peter J ^a,b   Padberg Jr , Frank T ^a,b   Cerveira, Joaquim J ^a,b   Hobson II, Robert W ^a   Durán, Walter N ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBRONECTIN; POLYSTYRENE; TRANSFORMING GROWTH FACTOR BETA1; SCLEROPROTEIN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CHRONIC DISEASE; CHRONIC VEIN INSUFFICIENCY; CONTROLLED STUDY; DERMIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PUNCH BIOPSY; VENOUS STASIS; CELL FUNCTION; CELL MOTION; IN VITRO STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; VARICOSIS;

CELL MOVEMENT; CELL PHYSIOLOGY; CHRONIC DISEASE; DERMIS; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; HUMANS; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VARICOSE ULCER;

EID: 0037734185     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(02)75295-6     Document Type: Article

References (32)

1. Higley HR, Ksander GA, Gerhardt CO, Falanga V. Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration. Br J Dermatol 1995;132:79-85.
2. 1 gene expression and protein production. J Vasc Surg 1999;30:1129-45.
3. Saito S, Trovato MJ, You R, Lal BK, Fasehun F, Padberg FT Jr, et al. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency. J Vasc Surg 2001;34:930-8.
4. Pappas PJ, DeFouw DO, Venezio LM, Gorti R, Padberg FT Jr, Silva MB Jr, et al. Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency. J Vasc Surg 1997;26:784-95.
5. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. I: Paracrine cells important in health and disease. Am J Physiol 1999;277(Pt 1):C1-9.
6. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286-92.
7. Masur SK, Dewal HS, Dinh TT, Erenburg I, Petridou S. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc Natl Acad Sci U S A 1996;93:4219-23.
8. Mauch C, Kreig T. Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis. Rheum Dis Clin North Am 1990;16:93-107.
9. Bitterman PB, Rennard SI, Adelberg S, Crystal RG. Role of fibronectin as a growth factor for fibroblasts. J Cell Biol 1983;97:1925-32.
10. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM. Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994;127(Pt 2):2037-48.
11. Eckes B, Zigrino P, Kessler D, Holtkotter O, Shephard P, Mauch C, et al. Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol 2000;19:325-32.
12. Mendez MV, Stanley A, Phillips T, Murphy M, Menzoian JO, Park HY. Fibroblasts cultured from distal lower extremities in patients with venous reflux display cellular characteristics of senescence. J Vasc Surg 1998;28:1040-50.
13. Mendez MV, Stanley A, Park HY, Shon K, Phillips T, Menzoian JO. Fibroblasts cultured from venous ulcers display cellular characteristics of senescence. J Vasc Surg 1998;28:876-83.
14. Araki CT, Back TL, Padberg FT Jr, Thompson PN, Duran WN, Hobson RW. Refinements in the ultrasonic detection of popliteal vein reflux. J Vasc Surg 1993;18:742-8.
15. Classification and grading of chronic venous disease in the lower limbs: A consensus statement. Ad Hoc Committee, American Venous Forum. J Cardiovasc Surg (Torino) 1997;38:437-41.
16. Pappas PJ, Gwertzman GA, DeFouw DO, Padberg FT Jr, Silva MB Jr, Duran WN, et al. Retinoblastoma protein: A molecular regulator of chronic venous insufficiency. J Surg Res 1998;76:149-53.
17. Travers JP, Brookes CE, Evans J, Baker DM, Kent C, Makin GS, et al. Assessment of wall structure and composition of varicose veins with reference to collagen, elastin and smooth muscle content. Eur J Vasc Endovasc Surg 1996;11:230-7.
18. Porter JM, Moneta GL. Reporting standards in venous disease: An update. International Consensus Committee on Chronic Venous Disease. J Vasc Surg 1995;21:635-45.
19. Kovacs EJ, DiPietro LA. Fibrogenic cytokines and connective tissue production. FASEB J 1994;8:854-61.
20. Pappas PJ, Fallek SR, Garcia A, Araki CT, Back TL, Duran WN, et al. Role of leukocyte activation in patients with venous stasis ulcers. J Surg Res 1995;59:553-9.
21. Eckes B, Kessler D, Aumailley M, Krieg T. Interactions of fibroblasts with the extracellular matrix: Implications for the understanding of fibrosis. Springer Semin Immunopathol 1999;21:415-29.
22. Burnand KG, Whimster I, Naidoo A, Browse NL. Pericapillary fibrin in the ulcer-bearing skin of the leg: The cause of lipodermatosclerosis and venous ulceration. BMJ 1982;285:1071-2.
23. 1 fails to stimulate wound healing and impairs its signal transduction in an aged ischemic ulcer model: Importance of oxygen and age. Am J Pathol 1999;154:301-9.
24. Robson MC, Philip LG, Cooper DM. Safety and effect of TGF beta for treatment of venous stasis ulcers. Wound Rep Reg 1995;2:157-67.
25. Falanga V, Eaglstein WH, Bucalo B, Katz MH, Harris B, Carson P. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Dermatol Surg Oncol 1992;18:604-6.
26. Stacey MC, Mata SD, Trengove NJ, Mather CA. Randomised double-blind placebo controlled trial of topical autologous platelet lysate in venous ulcer healing. Eur J Vasc Endovasc Surg 2000;20:296-301.
27. Grinnell F. Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 1994;124:401-4.
28. Morin G, Rand M, Burgess LP, Voussoughi J, Graeber GM. Wound healing: Relationship of wound closing tension to tensile strength in rats. Laryngoscope 1989;99(Pt 1):783-8.
29. Kawakami T, Ihn H, Xu W, Smith E, LeRoy C, Trojanowska M. Increased expression of TGF-beta receptors by scleroderma fibroblasts: Evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype. J Invest Dermatol 1998;110:47-51.
30. Humphries MJ, Ayad SR. Stimulation of DNA synthesis by cathepsin D digests of fibronectin. Nature 1983;305:811-3.
31. Magnusson MK, Mosher DF. Fibronectin: structure, assembly, and cardiovascular implications. Arterioscler Thromb Vasc Biol 1998;18:1363-70.
32. Serini G, Gabbiani G. Mechanisms of myofibroblast activity and phenotypic modulation. Exp Cell Res 1999;250:273-83.